Ajlan, Abdulrazag <br/><br/>
Optimizing bevacizumab dosing in glioblastoma: less is more.  [electronic resource] 

 -  Journal of neuro-oncology  Oct 2017 
 - 99-105 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7373 
<br/><br/><label>Standard No.: </label>10.1007/s11060-017-2553-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Chemoradiotherapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Survival Analysis<br/>Treatment Outcome